LNWTC
GMAB icon

Laird Norton Wetherby Trust Company’s Genmab GMAB Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$341K Sell
12,414
-3,476
-22% -$92.4K 0.01% 833
2026
Q1 		$426K Buy
15,890
+51
+0.3% +$1.53K 0.01% 737
2025
Q4 		$488K Buy
+15,839
New +$494K 0.01% 725

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Laird Norton Wetherby Trust Company's GMAB Position: Q2 2026 in Review

Laird Norton Wetherby Trust Company reduced its Genmab (GMAB) stake by 22% in Q2 2026, selling an estimated $92.4K and leaving 12,414 shares worth $341K. The position accounts for 0.01% of the portfolio, ranked #833.

Laird Norton Wetherby Trust Company first reported a position in GMAB in Q4 2025 and has held it in 3 quarters since. The position peaked at $488K in Q4 2025. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Laird Norton Wetherby Trust Company held 12,414 shares of Genmab worth $341K as of Q2 2026.
  • Laird Norton Wetherby Trust Company sold 3,476 Genmab shares in Q2 2026, an estimated $92.4K.
  • Genmab made up 0.01% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #833 holding.
  • Laird Norton Wetherby Trust Company first reported a position in Genmab in Q4 2025 and has held it in 3 quarters since.
  • Laird Norton Wetherby Trust Company's Genmab position peaked at $488K in Q4 2025.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.